There was one final vaccine-related gift from the outgoing Biden administration to the makers of mRNA vaccines — only this time, it didn’t have to do with COVID inoculations.
According to a Friday news release by the Department of Health and Human Services, the department was giving a nearly $600 million grant to Moderna to “accelerate pandemic influenza mRNA-based vaccine development.”
Moderna was one of two major U.S.-based companies to develop mRNA vaccines for use against COVID-19, the other being Pfizer.
Trending: BREAKING: President Trump STUNS officials at DOJ with new firings
This time, however, the vaccines being funded will target influenza, along with aiming to “enhance mRNA platform capabilities so that the U.S. is better prepared to respond to other emerging infectious diseases.”
“The award was made through the Rapid Response Partnership Vehicle (RRPV) Consortium
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!